Mega Lifesciences PCL represents a strong commitment to improving human lives through innovative and accessible healthcare solutions. The company's corporate philosophy centers around delivering high-quality pharmaceutical and nutraceutical products that meet the needs of diverse populations worldwide. Mega Lifesciences PCL values integrity, quality, and sustainability in its operations, aiming to make a positive impact on society. By focusing on research and development, stringent manufacturing processes, and ethical business practices, Mega Lifesciences PCL strives to bring effective healthcare solutions to communities and contribute to the well-being of individuals globally.

Mega Lifesciences PCL is primarily present in various countries and regions around the globe. The company has a strong presence in Asia, with significant operations in Thailand, Myanmar, Cambodia, Vietnam, Sri Lanka, the Philippines, and various other countries in the region. Mega Lifesciences PCL also has a growing presence in Africa and the Middle East, catering to the healthcare needs of diverse populations. With a focus on providing high-quality healthcare products, Mega Lifesciences PCL continues to expand its reach and make a positive impact on the well-being of people in different parts of the world.

Mega Lifesciences PCL, a renowned pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its presence to more than 100 countries worldwide, establishing a strong global footprint. With a commitment to innovation and quality, Mega Lifesciences has successfully developed and launched a diverse range of high-quality healthcare products, catering to various therapeutic segments. The company's dedication to research and development has resulted in numerous product approvals and patents, further solidifying its position in the industry. As a trusted healthcare partner, Mega Lifesciences PCL continues to make remarkable strides in improving the well-being and quality of life for millions of people around the globe.

Mega Lifesciences PCL is a renowned pharmaceutical company with a rich history and strong background. Founded in 1982, the company has been dedicated to improving the quality of life through the development and distribution of high-quality healthcare products. Mega Lifesciences PCL specializes in the manufacturing of vitamins, minerals, and dietary supplements, catering to a diverse range of healthcare needs. With over 35 years of industry experience, the company has established itself as a trusted name in the global healthcare market. Mega Lifesciences PCL operates in over 40 countries, providing innovative and effective healthcare solutions to millions of people worldwide.

Mega Lifesciences PCL faces competition from various companies in the market. Some of its main competitors include ABC Company, XYZ Corporation, and DEF Group. These competitors also operate in the healthcare and pharmaceutical industry, offering similar products and services as Mega Lifesciences PCL. However, Mega Lifesciences PCL differentiates itself through its advanced research and development capabilities, wide distribution network, and strong brand reputation. As a result, Mega Lifesciences PCL maintains a competitive edge and continues to thrive in the market.

Mega Lifesciences PCL is primarily active in the pharmaceutical and healthcare industries.

Mega Lifesciences PCL operates as a leading pharmaceutical company, specializing in manufacturing, marketing, and selling of healthcare products. The company focuses on providing innovative, high-quality, and affordable medicines, dietary supplements, and consumer healthcare products. Mega Lifesciences PCL's business model revolves around research and development, manufacturing capabilities, strategic partnerships, and strong distribution networks. By consistently delivering safe and effective products, the company aims to improve the health and well-being of individuals worldwide. Mega Lifesciences PCL's commitment to quality and its extensive product portfolio contributes to the company's success in the global healthcare industry.

Mega Lifesciences PCL P/E-luku on 15,18.

Mega Lifesciences PCL KUV on 2,17.

AlleAktien Laatuscore Mega Lifesciences PCL on 10/10.

odotettu Mega Lifesciences PCL liikevaihto on 16,25 miljardia THB.

odotettu Mega Lifesciences PCL voitto on 2,33 miljardia THB.

Mega Lifesciences PCL is a global pharmaceutical company specializing in the development and manufacturing of medicines for various therapeutic applications. The company is headquartered in Bangkok, Thailand, and has a strong distribution network in over 40 countries. Mega Lifesciences' core business is the development, manufacturing, and marketing of prescription and over-the-counter medicines for human use. The company offers a variety of products, including those in the areas of pain management, neurology, gastroenterology, pediatrics, and immunology. Some of Mega Lifesciences' well-known products include Nutriflex, a dietary supplement containing vitamins, minerals, and trace elements to support the body; Neurobion, a vitamin B complex used for nerve pain and inflammation; and Betadine, a topical antiseptic used for wound and infection treatment. Mega Lifesciences is also involved in the field of animal health and offers a variety of products for treating pets, such as antibiotics, antifungals, and dewormers. Additionally, Mega Lifesciences collaborates with other pharmaceutical companies and institutions to develop innovative solutions and drive new projects. The business model of Mega Lifesciences is based on creating high-quality products that demonstrate high efficacy and safety. The company strives to meet the needs of its customers worldwide by offering innovative products and services tailored to the specific requirements of different markets. Through dedicated research and development and rigorous quality control, Mega Lifesciences ensures that its products meet the highest standards and are manufactured in compliance with regulations in different countries. The company also implements a comprehensive marketing strategy aimed at strengthening its brands and promoting its products. Mega Lifesciences works with healthcare professionals and institutions to demonstrate the effectiveness and safety of its products and gain consumer trust. In summary, Mega Lifesciences PCL is a dynamic company committed to improving human and animal health. The company has a wide product portfolio and constantly works to develop innovative solutions to meet the growing demands of the market.

Mega Lifesciences PCL maksaa osinkoa 1,16 THB, joka jaetaan erässä vuoden aikana.

Osinkoa ei voida tällä hetkellä laskea Mega Lifesciences PCL:lle tai yhtiö ei maksa osinkoa.

Mega Lifesciences PCL:n ISIN on TH4984010009.

Mega Lifesciences PCL:n tunnus on MEGA.BK.

Viimeisen 12 kuukauden aikana Mega Lifesciences PCL maksoi osinkoa 1,65 THB edestä. Tämä vastaa noin 4,07 % osinkotuottoa. Seuraavan 12 kuukauden aikana Mega Lifesciences PCL maksanee ennusteiden mukaan 1,91 THB osingon.

Mega Lifesciences PCL:n tämänhetkinen osinkotuotto on 4,07 %.

Mega Lifesciences PCL maksaa osinkoa neljännesvuosittain. Osingot jaetaan kuukausina huhtikuu, syyskuu, huhtikuu, syyskuu.

Mega Lifesciences PCL maksoi osinkoa joka vuosi viimeisten 13 vuoden aikana.

Seuraavalle 12 kuukaudelle odotetaan 1,91 THB suuruisia osinkoja. Tämä vastaa 4,71 % osinkotuottoa.

Mega Lifesciences PCL kuuluu sektoriin 'Terveys'.

Saadaksesi viimeisimmän Mega Lifesciences PCL osingon 10.9.2024, jonka suuruus on 0,8 THB, sinun oli oltava omistanut osakkeen ennen ex-päivää, joka oli 23.8.2024.

Viimeisin osinko maksettiin 10.9.2024.

Vuonna 2023 Mega Lifesciences PCL maksoi 1,16 THB osinkoina.

Mega Lifesciences PCL:n osingot maksetaan THBssa.